Application 206120
- Type
- ANDA
- Sponsor
- MYLAN LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | TABLET, CHEWABLE;ORAL | 0.02MG;1MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A206120-001 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | 0.02MG;1MG | TABLET / ORAL | 2017-09-12 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A206120-001 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | 0.02MG;1MG | TABLET / ORAL | 2017-09-12 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | Glenmark Pharmaceuticals Inc., USA | 3e608414-5e64-4c69-a9e0-365904cf7df8 | 2026-01-31 | Boxed warning, Warnings, Adverse reactions | Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate |
| Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | Amneal Pharmaceuticals NY LLC | d4fa03d8-0ae0-497f-ba4e-76f03fd7a3ab | 2023-07-18 | Boxed warning, Warnings, Adverse reactions | Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate |
| NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | Mylan Pharmaceuticals Inc. | 054917fa-573b-4b16-a719-ece6c0909656 | 2021-11-29 | Boxed warning, Warnings, Adverse reactions | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE |
| norethindrone acetate and ethinyl estradiol and ferrous fumarate | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | Glenmark Pharmaceuticals Inc., USA | 570670c0-b88f-4e78-a978-498aff52b410 | 2017-12-26 | Boxed warning, Warnings, Adverse reactions | norethindrone acetate and ethinyl estradiol and ferrous fumarate |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-7315 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | norethindrone acetate and ethinyl estradiol and ferrous fumarate | Mylan Pharmaceuticals Inc. | ANDA | Current |